ARTICLE | Company News
R-Biopharm, Apogenix deal
September 14, 2015 7:00 AM UTC
R-Biopharm and Apogenix partnered to develop companion diagnostics for Apogenix’s APG101. APG101 is in development to treat solid tumors and malignant hematological diseases and is slated to begin a ...